{
  "author": {
    "name": "Anna Edney Robert Langreth",
    "webUrl": "/author/profile/anna-edney-robert-langreth/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2017/06/09/fda-in-milestone-for-opioid-crisis-asks-endo-to-pu/",
        "title": "FDA, in milestone for opioid crisis, asks Endo to pull pill",
        "byline": " Anna Edney, Robert Langreth ",
        "kicker": "",
        "prettyDate": "June 09, 2017",
        "timeToRead": "4 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/anna-edney-robert-langreth/",
            "name": "Anna Edney, Robert Langreth"
          }
        ],
        "kickerNode": [],
        "summary": "Amid an outbreak of dangerous infections by pain drug abusers, the U.S. FDA has asked Endo to stop sales of its powerful opioid painkiller Opana ER.",
        "body": null
      }
    ]
  }
}